Protocol to Generate Senescent Cells from the Mouse Hepatic Cell Line AML12 to Study Hepatic Aging
Summary: Previously developed senescent primary fibroblast models have limited relevance to study age-related changes in metabolically active tissues such as the liver. Here, we describe a protocol to generate senescent cells from the mouse hepatic cell line, AML12. These senescent cells exhibit mol...
Main Authors: | Madhulika Tripathi, Paul Michael Yen, Brijesh Kumar Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | STAR Protocols |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166720300514 |
Similar Items
-
Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
by: Eveline Bruinstroop, et al.
Published: (2021-11-01) -
Endoplasmic Reticulum Protein TXNDC5 Interacts with PRDX6 and HSPA9 to Regulate Glutathione Metabolism and Lipid Peroxidation in the Hepatic AML12 Cell Line
by: Seyed Hesamoddin Bidooki, et al.
Published: (2023-12-01) -
Squalene Loaded Nanoparticles Effectively Protect Hepatic AML12 Cell Lines against Oxidative and Endoplasmic Reticulum Stress in a TXNDC5-Dependent Way
by: Seyed Hesamoddin Bidooki, et al.
Published: (2022-03-01) -
The Cytolethal Distending Toxin Subunit CdtB of Helicobacter hepaticus Promotes Senescence and Endoreplication in Xenograft Mouse Models of Hepatic and Intestinal Cell Lines
by: Christelle Péré-Védrenne, et al.
Published: (2017-06-01) -
Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials
by: Tahsin Anwar, et al.
Published: (2023-12-01)